婴儿危重先天性心脏病的综合临床遗传学方法
该回顾性研究纳入293例<1月龄危重先天性心脏病(CHD)婴儿,采用综合心血管遗传学评估,总体遗传检测异常率为26%。多发性先天畸形组的异常率(39%)高于孤立性CHD组(20%)(OR 2.7)。右心室梗阻性缺陷、耳鼻喉及脑异常、小于胎龄儿或宫内生长迟缓、面容异常与遗传检测异常相关。
要点
- 危重CHD婴儿总体遗传检测异常率为26%。
- 多发性先天畸形组遗传检测异常率高于孤立性CHD组(39% vs 20%,OR 2.7)。
- 右心室梗阻性缺陷、耳鼻喉或脑异常、小于胎龄儿/宫内生长迟缓、面容异常与遗传检测异常相关。
核心结论
- 研究支持对危重CHD婴儿采用综合心血管遗传学评估方法,并识别了重要的基因型-表型考量因素。
研究设计与样本
- 回顾性图表审查,纳入2010至2015年在一家儿童心脏重症监护室接受心血管遗传学评估的<1月龄CHD婴儿。
- 共纳入293例婴儿,其中213例为孤立性先天性心脏病(iCHD),80例为多发性先天畸形。
- CHD采用结构化表型定义分类,使用χ1检验和Fisher精确检验分析心脏及非心脏表型与遗传检测异常的关联。
主要发现
- 总体遗传检测异常率为26%。
- 多发性先天畸形队列遗传检测异常率(39%)高于iCHD队列(20%)(OR 2.7)。
- 采用非层次CHD分类并排除22q11.2缺失和常见非整倍体后,右心室梗阻性缺陷与遗传检测异常相关(P = .0005)。
- 与遗传检测异常相关的非心脏特征包括耳鼻喉异常(P = .003)和脑异常(P = .0001)。
- 小于胎龄儿或宫内生长迟缓(P = .0061)及面容异常(P = .0033,OR 3.5)也与遗传检测异常相关。
关键数值与推荐
- 总体遗传检测异常率26%;多发性先天畸形组39%,iCHD组20%(OR 2.7)。
- 右心室梗阻性缺陷与遗传检测异常相关(P = .0005,排除22q11.2缺失和常见非整倍体后)。
- 耳鼻喉异常(P = .003)、脑异常(P = .0001)、小于胎龄儿或宫内生长迟缓(P = .0061)、面容异常(P = .0033,OR 3.5)与遗传检测异常相关。
临床怎么用
- 对危重CHD婴儿应进行综合心血管遗传学评估以明确遗传诊断。
- 评估时需关注右心室梗阻性缺陷、耳鼻喉及脑异常、小于胎龄儿/宫内生长迟缓、面容异常等与遗传检测异常相关的表型特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the frequency of genetic diagnoses among infants with critical congenital heart disease (CHD) using a comprehensive cardiovascular genetics approach and to identify genotype-phenotype correlations. STUDY DESIGN: A retrospective chart review of patients evaluated by cardiovascular genetics in a pediatric cardiac intensive care unit from 2010 to 2015 was performed. Infants with CHD who were <1 month of age were included. CHD was classified using structured phenotype definitions. Cardiac and noncardiac phenotypes were tested for associations with abnormal genetic testing using χ1 and Fisher exact tests. RESULTS: Genetic evaluation was completed in 293 infants with CHD, of whom 213 had isolated congenital heart disease (iCHD) and 80 had multiple congenital anomalies. Overall, the yield of abnormal genetic testing was 26%. The multiple congenital anomalies cohort had a greater yield of genetic testing (39%) than the iCHD cohort (20%) (OR 2.7). Using a non-hierarchical CHD classification and excluding 22q11.2 deletion and common aneuploidies, right ventricular obstructive defects were associated with abnormal genetic testing (P = .0005). Extracardiac features associated with abnormal genetic testing included ear, nose, and throat (P = .003) and brain (P = .0001) abnormalities. A diagnosis of small for gestational age or intrauterine growth retardation also was associated with abnormal genetic testing (P = .0061), as was presence of dysmorphic features (P = .0033, OR 3.5). Infants without dysmorphia with iCHD or multiple congenital anomalies had similar frequencies of abnormal genetic testing. CONCLUSIONS: The present study provides evidence to support a comprehensive cardiovascular genetics approach in evaluating infants with critical CHD while also identifying important genotype-phenotype considerations.
引用
- Shikany AR, Landis BJ, Parrott A, et al. A Comprehensive Clinical Genetics Approach to Critical Congenital Heart Disease in Infancy. J Pediatr. 2020. PMID: 32717230. doi:10.1016/j.jpeds.2020.07.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。